CA2008771A1 - Nitrate de pyridinium, sa fabrication et ses usages - Google Patents

Nitrate de pyridinium, sa fabrication et ses usages

Info

Publication number
CA2008771A1
CA2008771A1 CA2008771A CA2008771A CA2008771A1 CA 2008771 A1 CA2008771 A1 CA 2008771A1 CA 2008771 A CA2008771 A CA 2008771A CA 2008771 A CA2008771 A CA 2008771A CA 2008771 A1 CA2008771 A1 CA 2008771A1
Authority
CA
Canada
Prior art keywords
production
pyridinium nitrate
pyridinium
nitrate
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2008771A
Other languages
English (en)
Other versions
CA2008771C (fr
Inventor
Susumu Tsushima
Muneo Takatani
Kohei Nishikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2008771A1 publication Critical patent/CA2008771A1/fr
Application granted granted Critical
Publication of CA2008771C publication Critical patent/CA2008771C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
CA002008771A 1989-01-30 1990-01-29 Nitrate de pyridinium, sa fabrication et ses usages Expired - Fee Related CA2008771C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2191989 1989-01-30
JP021919-1989 1989-01-30

Publications (2)

Publication Number Publication Date
CA2008771A1 true CA2008771A1 (fr) 1990-07-30
CA2008771C CA2008771C (fr) 1999-03-23

Family

ID=12068486

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002008771A Expired - Fee Related CA2008771C (fr) 1989-01-30 1990-01-29 Nitrate de pyridinium, sa fabrication et ses usages

Country Status (9)

Country Link
US (1) US4981860A (fr)
EP (1) EP0382380B1 (fr)
JP (1) JP2765155B2 (fr)
KR (1) KR0143413B1 (fr)
AT (1) ATE93855T1 (fr)
CA (1) CA2008771C (fr)
DE (1) DE69002959T2 (fr)
DK (1) DK0382380T3 (fr)
ES (1) ES2058779T3 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2068742B1 (es) * 1993-02-11 1995-11-16 Uriach & Cia Sa J Nuevos derivados de piridinio.
US5496855A (en) * 1995-01-27 1996-03-05 Smithkline Beecham Corp. Anti-inflammatory compounds
AU5514196A (en) * 1995-04-27 1996-11-18 Takeda Chemical Industries Ltd. Agent for severe acute pancreatitis
WO1998004547A1 (fr) * 1996-07-25 1998-02-05 Takeda Chemical Industries, Ltd. Derives cristallins de pyridinium en tant qu'antagonistes du facteur d'activation des plaquettes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK160818C (da) * 1983-12-30 1991-10-07 Hoffmann La Roche N-ring-holdige glycerolderivater, fremgangsmaade til fremstilling deraf, anvendelse deraf til fremstilling af et blodpladeaktiveringsfaktorhaemmende middel samt laegemidler indeholdende en saadan forbindelse
DE3879024T2 (de) * 1987-07-31 1993-10-07 Takeda Chemical Industries Ltd Pyridinium-Derivate, ihre Herstellung und Verwendung.

Also Published As

Publication number Publication date
KR0143413B1 (ko) 1998-07-15
JPH02275876A (ja) 1990-11-09
DE69002959T2 (de) 1994-03-24
ATE93855T1 (de) 1993-09-15
EP0382380B1 (fr) 1993-09-01
JP2765155B2 (ja) 1998-06-11
DK0382380T3 (da) 1994-01-10
KR900011757A (ko) 1990-08-02
ES2058779T3 (es) 1994-11-01
US4981860A (en) 1991-01-01
DE69002959D1 (de) 1993-10-07
CA2008771C (fr) 1999-03-23
EP0382380A1 (fr) 1990-08-16

Similar Documents

Publication Publication Date Title
FI885594A0 (fi) Tiazolidindioner anvaendbara foer saenkande av blodsockerhalten samt atherosklerosis hindrande medel.
EP0313393A3 (fr) Composés benzoxazines et leur utilisation pharmaceutique
AU3479889A (en) New antiviral drug
AU4540789A (en) Imide derivatives, and their production and use
EP0614913A3 (fr) Dérivés de la dynorphine.
IE882335L (en) Pyridinium derivatives, their production and use
EP0314098A3 (en) Imide derivatives, their production and use
FI895185A0 (fi) Mevalonolaktoner av tienopyridintyp.
DK297385D0 (da) Carbapenemer med externt alkyleret mono- eller bicyclisk heteroarylalkylthiosubstituent samt laegemiddel indeholdende saadanne forbindelser
ATE86860T1 (de) Praeparat gegen ulcus.
DE69121259D1 (de) Beta-Lactam-Verbindungen und ihre Herstellung
CA2008771A1 (fr) Nitrate de pyridinium, sa fabrication et ses usages
TW228520B (fr)
DK297485A (da) Carbapenemer med kvaternaere heteroarylalkylthio 2-substituenter samt laegemiddel indeholdende saadanne forbindelser
FI915245A0 (fi) 7-acyl-3-(substitueradkarbamoyloxi) cefemfoereningar samt foerfarande foer framstaellning av dessa.
IE894058L (en) Novel bis-arylphosphate ester antagonists of platelet¹activating factor
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
AU6653190A (en) Fungicides
ES2053079T3 (es) Piridazinaminas con actividad anti-rinoviral.
AU2704492A (en) Improvements in or relating to organic compounds
AU4617193A (en) Heteroarenylpiperazines, a process for their preparation and their use as medicaments
EP0376598A3 (fr) Dérivés de pyrazole et leur préparation et application
DE3362523D1 (en) Optically active imidazolylpropanol compounds, and their production and use
AU4706489A (en) Oxadiazol-azabicycl compounds and their pharmaceutical use

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed